149 related articles for article (PubMed ID: 29048134)
21. [Disseminated necrobiotic xanthogranuloma].
Klingner M; Hansel G; Schönlebe J; Wollina U
Hautarzt; 2016 Nov; 67(11):902-906. PubMed ID: 27380383
[TBL] [Abstract][Full Text] [Related]
22. Necrobiotic xanthogranuloma treated with a combination of oral methylprednisolone and cyclosporin.
Lee HJ; Kim JM; Kim GW; Kim HS; Kim BS; Kim MB; Ko HC
J Dermatol; 2017 Oct; 44(10):1190-1191. PubMed ID: 27790743
[No Abstract] [Full Text] [Related]
23. Necrobiotic xanthogranuloma of the extremities.
Wolz M; Peters MS
J Drugs Dermatol; 2012 Jan; 11(1):122-3. PubMed ID: 22206088
[No Abstract] [Full Text] [Related]
24. An unusual histologic variant of necrobiotic xanthogranuloma.
Ziemer M; Norgauer J; Simon JC; Koehler MJ
Am J Dermatopathol; 2012 Apr; 34(2):e22-6. PubMed ID: 22441374
[TBL] [Abstract][Full Text] [Related]
25. Generalized necrobiotic xanthogranuloma successfully treated with lenalidomide.
Silapunt S; Chon SY
J Drugs Dermatol; 2010 Mar; 9(3):273-6. PubMed ID: 20232591
[TBL] [Abstract][Full Text] [Related]
26. Thalidomide and lenalidomide for the treatment of refractory dermatologic conditions.
Nahmias Z; Nambudiri VE; Vleugels RA
J Am Acad Dermatol; 2016 Jul; 75(1):210-2. PubMed ID: 27317516
[No Abstract] [Full Text] [Related]
27. Pomalidomide: when expectations are understated.
Di Raimondo F; Conticello C
Future Oncol; 2017 Feb; 13(5s):1-2. PubMed ID: 28116940
[No Abstract] [Full Text] [Related]
28. Recent advances of IMiDs in cancer therapy.
Li S; Gill N; Lentzsch S
Curr Opin Oncol; 2010 Nov; 22(6):579-85. PubMed ID: 20689431
[TBL] [Abstract][Full Text] [Related]
29. Use of lenalidomide in treating refractory prurigo nodularis.
Liu H; Gaspari AA; Schleichert R
J Drugs Dermatol; 2013 Mar; 12(3):360-1. PubMed ID: 23545923
[TBL] [Abstract][Full Text] [Related]
30. Novel immunomodulatory compounds in multiple myeloma.
Saini N; Mahindra A
Expert Opin Investig Drugs; 2013 Feb; 22(2):207-15. PubMed ID: 23265189
[TBL] [Abstract][Full Text] [Related]
31. Treatment of Patients With Myelodysplastic Syndrome With Lenalidomide in Clinical Routine in Austria.
Aschauer G; Greil R; Linkesch W; Nösslinger T; Stauder R; Burgstaller S; Fiegl M; Fridrik M; Girschikofsky M; Keil F; Petzer A
Clin Lymphoma Myeloma Leuk; 2015 Nov; 15(11):e143-9. PubMed ID: 26422252
[TBL] [Abstract][Full Text] [Related]
32. Thalidomide and lenalidomide in multiple myeloma.
Mazumder A; Jagannath S
Best Pract Res Clin Haematol; 2006; 19(4):769-80. PubMed ID: 16997182
[TBL] [Abstract][Full Text] [Related]
33. Adult-onset asthma and periocular xanthogranuloma with orbital involvement: A rare entity.
Mukherjee B; Shrirao N
Ann Allergy Asthma Immunol; 2016 May; 116(5):466-7. PubMed ID: 27017561
[No Abstract] [Full Text] [Related]
34. Necrobiotic xanthogranuloma.
Jaén-Águila F; Vargas-Hitos JA; Jiménez-Alonso J
QJM; 2014 Oct; 107(10):859. PubMed ID: 24659748
[No Abstract] [Full Text] [Related]
35. Aberrant expression of the microRNA cluster in 14q32 is associated with del(5q) myelodysplastic syndrome and lenalidomide treatment.
Krejčík Z; Beličková M; Hruštincová A; Kléma J; Zemanová Z; Michalová K; Čermák J; Jonášová A; Dostálová Merkerová M
Cancer Genet; 2015 Apr; 208(4):156-61. PubMed ID: 25883014
[TBL] [Abstract][Full Text] [Related]
36. Necrobiotic xanthogranuloma: response to dapsone.
Wei YH; Cheng JJ; Wu YH; Liu CY; Hung CJ; Hsu JD; Hsiao YP
Dermatol Ther; 2015; 28(1):7-9. PubMed ID: 25314033
[No Abstract] [Full Text] [Related]
37. A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: the EXPECT trial.
Morschhauser F; Fitoussi O; Haioun C; Thieblemont C; Quach H; Delarue R; Glaisner S; Gabarre J; Bosly A; Lister J; Li J; Coiffier B
Eur J Cancer; 2013 Sep; 49(13):2869-76. PubMed ID: 23731832
[TBL] [Abstract][Full Text] [Related]
38. Letter: Necrobiotic xanthogranuloma of extremities in an elderly patient successfully treated with low-dose prednisolone.
Kawakami Y; Yamamoto T
Dermatol Online J; 2011 Jun; 17(6):13. PubMed ID: 21696693
[TBL] [Abstract][Full Text] [Related]
39. Treatment of necrobiotic xanthogranuloma - a systematic review.
Miguel D; Lukacs J; Illing T; Elsner P
J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):221-235. PubMed ID: 27436448
[TBL] [Abstract][Full Text] [Related]
40. [Desensitization to lenalidomide].
Cañamares Orbis I; García Muñoz C; Cortijo Cascajares S; Méndez Esteban ME
Farm Hosp; 2012; 36(6):542-3. PubMed ID: 23461448
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
